Peter R. Gwilt

1.2k total citations
44 papers, 963 citations indexed

About

Peter R. Gwilt is a scholar working on Molecular Biology, Oncology and Spectroscopy. According to data from OpenAlex, Peter R. Gwilt has authored 44 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Spectroscopy. Recurrent topics in Peter R. Gwilt's work include Analytical Chemistry and Chromatography (6 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Peter R. Gwilt is often cited by papers focused on Analytical Chemistry and Chromatography (6 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Peter R. Gwilt collaborates with scholars based in United States, Belgium and Switzerland. Peter R. Gwilt's co-authors include William Tracewell, Donald Perrier, Jing Li, Jasmine Davda, Jing Li, Maneesh Jain, Donald H. Waters, Surinder K. Batra, Dennis H. Robinson and Randall B. Smith and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Journal of Chromatography A.

In The Last Decade

Peter R. Gwilt

43 papers receiving 919 citations

Peers

Peter R. Gwilt

ONCOL

PHARM

GENET

RNMI

Christopher James United States

B McConkey United Kingdom

Arthur L. Sagone United States

Stephen A. Bai United States

Hans Erik Rugstad Norway

Peter Seideman Sweden

F Trivin France

Gérard Flesch Switzerland

Ronald de Vries Belgium

L.F. Lacey United Kingdom

Christopher James United States

Peter R. Gwilt

255 ×1.1

169 ×0.8

ONCOL

54 ×0.5

PHARM

78 ×0.7

GENET

55 ×0.5

RNMI

Citations per year, relative to Peter R. Gwilt Peter R. Gwilt (= 1×) peers Christopher James

Countries citing papers authored by Peter R. Gwilt

Since Specialization

Citations

This map shows the geographic impact of Peter R. Gwilt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Gwilt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Gwilt more than expected).

Fields of papers citing papers by Peter R. Gwilt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Gwilt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Gwilt. The network helps show where Peter R. Gwilt may publish in the future.

Co-authorship network of co-authors of Peter R. Gwilt

This figure shows the co-authorship network connecting the top 25 collaborators of Peter R. Gwilt. A scholar is included among the top collaborators of Peter R. Gwilt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter R. Gwilt. Peter R. Gwilt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McGuire, Timothy R., et al.. (2012). Clinical pharmacology of etoposide in children undergoing autologous stem cell transplantation for various solid tumours. Xenobiotica. 43(3). 276–282. 2 indexed citations

Davda, Jasmine, Maneesh Jain, Surinder K. Batra, Peter R. Gwilt, & Dennis H. Robinson. (2007). A physiologically based pharmacokinetic (PBPK) model to characterize and predict the disposition of monoclonal antibody CC49 and its single chain Fv constructs. International Immunopharmacology. 8(3). 401–413. 84 indexed citations

Chauhan, Subhash C., Maneesh Jain, Uwe A. Wittel, et al.. (2004). Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49. European Journal of Nuclear Medicine and Molecular Imaging. 32(3). 264–273. 21 indexed citations

Sunkara, Gangadhar, et al.. (2003). Pathways and Kinetics of Deslorelin Degradation in an Airway Epithelial Cell Line (Calu-1). Pharmaceutical Research. 20(5). 779–787. 4 indexed citations

Gwilt, Peter R., et al.. (2003). Pharmacokinetics of Hydroxyurea in Plasma and Cerebrospinal Fluid of HIV‐1‐Infected Patients. The Journal of Clinical Pharmacology. 43(9). 1003–1007. 15 indexed citations

Li, Jing & Peter R. Gwilt. (2003). The effect of age on the early disposition of doxorubicin. Cancer Chemotherapy and Pharmacology. 51(5). 395–402. 53 indexed citations

Lawson, Terence, et al.. (2002). In vitro pharmacokinetics and pharmacodynamics of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Biochemical Pharmacology. 63(7). 1209–1218. 27 indexed citations

Gwilt, Peter R., et al.. (2000). Pharmacokinetics of levamisole in cancer patients treated with 5-fluorouracil. Cancer Chemotherapy and Pharmacology. 45(3). 247–251. 18 indexed citations

Gwilt, Peter R., et al.. (1998). Pharmacokinetics of 2‐Oxothiazolidine‐4‐Carboxylate, a Cysteine Prodrug, and Cysteine. The Journal of Clinical Pharmacology. 38(10). 945–950. 7 indexed citations

10.

Gordon, Bruce G., et al.. (1998). Assay for etoposide in human serum using solid-phase extraction and high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 707(1-2). 342–346. 19 indexed citations

11.

Tracewell, William, Donald L. Trump, William P. Vaughan, David C. Smith, & Peter R. Gwilt. (1995). Population pharmacokinetics of hydroxyurea in cancer patients. Cancer Chemotherapy and Pharmacology. 35(5). 417–422. 33 indexed citations

12.

Vaughan, William P., et al.. (1995). Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma.. Journal of Clinical Oncology. 13(5). 1089–1095. 10 indexed citations

13.

Smith, David C., William P. Vaughan, Peter R. Gwilt, & Donald L. Trump. (1993). A phase I trial of high-dose continuous-infusion hydroxyurea. Cancer Chemotherapy and Pharmacology. 33(2). 139–143. 9 indexed citations

14.

Lawson, Terence & Peter R. Gwilt. (1993). Clofibrate enhances the DNA damaging action and cytotoxicity of nitrosoureas. Cancer Letters. 70(1-2). 119–122. 2 indexed citations

15.

Gwilt, Peter R., et al.. (1991). The Effects of Diabetes Mellitus on Pharmacokinetics and Pharmacodynamics in Humans. Clinical Pharmacokinetics. 20(6). 477–490. 140 indexed citations

16.

Gwilt, Peter R., et al.. (1989). Time to Steady State following a Change in Dosing Rate. DICP. 23(6). 468–472. 1 indexed citations

17.

Gwilt, Peter R., Sandra D. Comer, Prasoon Chaturvedi, & Donald H. Waters. (1988). The influence of diffusional barriers on presystemic gut elimination.. Drug Metabolism and Disposition. 16(4). 521–526. 9 indexed citations

18.

Cook, Jack & Peter R. Gwilt. (1988). Calculations and application of mean residence times for drugs which demonstrate one-compartment distribution and Michaelis-Menten elimination.. Pharmaceutical Research. 5(3). 196–196. 5 indexed citations

19.

Smith, Randall B., Peter R. Gwilt, & Caroline Wright. (1983). Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men.. PubMed. 2(2). 139–43. 28 indexed citations

20.

Gwilt, Peter R., Marvin C. Pankaskie, & Joseph Mitala. (1982). The effect of oral castor oil on the disposition of methyprylon in intoxicated dogs. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 29(4). 381–383. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact